In-Vitro Anticancer Evaluation of Some Novel Thioureido-Benzensulfonamide Derivatives
Open Access
Abstract
A novel series of sulfonamide derivatives (14 compounds) bearing thiourea moieties were efficiently synthesized and evaluated for their possible in vitro anticancer activity against four human tumor cell lines. The results indicated that compound 6 was the most potent, showing effectiveness on all the tested cell lines. Compounds 7 and 10 also showed promising results.Keywords
Funding Information
- King Abdulaziz City for Science and Technology (13-MED 997-02)
This publication has 19 references indexed in Scilit:
- Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modelingEuropean Journal of Medicinal Chemistry, 2014
- Synthesis of novel benzimidazole functionalized chiral thioureas and evaluation of their antibacterial and anticancer activitiesBioorganic & Medicinal Chemistry Letters, 2014
- Synthesis and anticancer activity of acyl thioureas bearing pyrazole moietyBioorganic & Medicinal Chemistry, 2013
- Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agentsBioorganic & Medicinal Chemistry, 2013
- Inhibition of carbonic anhydrase IX as a novel anticancer mechanismWorld Journal of Clinical Oncology, 2012
- Pteridine–sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activityBioorganic & Medicinal Chemistry, 2010
- Editorial [ Carbonic Anhydrases as Drug Targets Executive Editor: Claudiu T. Supuran ]Current Pharmaceutical Design, 2008
- Novel Nitrogen Mustard-Armed Combi-Molecules for the Selective Targeting of Epidermal Growth Factor Receptor Overexperessing Solid Tumors: Discovery of an Unusual Structure−Activity RelationshipJournal of Medicinal Chemistry, 2007
- Multitarget-Directed Drug Design Strategy: A Novel Molecule Designed To Block Epidermal Growth Factor Receptor (EGFR) and To Exert Proapoptotic EffectsJournal of Medicinal Chemistry, 2006
- Sulfonamides and Sulfonylated Derivatives as Anticancer AgentsCurrent Cancer Drug Targets, 2002